3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, Large B-Cell, Diffuse
19
Lymphoma, Follicular
12
Lymphoma
11
Rhabdomyosarcoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Recurrence
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Biphenotypic, Acute
7
Sarcoma, Ewing
6
Lymphoma, Non-Hodgkin
6
Lymphoma, B-Cell
6
Neuroblastoma
5
Neoplasms
5
Lymphoma, Mantle-Cell
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Wilms Tumor
3
Rhabdomyosarcoma, Embryonal
3
Osteosarcoma
3
Lymphoproliferative Disorders
3
Lymphoma, T-Cell
3
Down Syndrome
3
Sarcoma
2
Rhabdomyosarcoma, Alveolar
2
Rhabdoid Tumor
2
Medulloblastoma
2
Lymphoma, T-Cell, Peripheral
2
Interventions
pembrolizumab
1
LY2940680
1
Cryotherapy
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Retinoblastoma
×
Vincristine
×
90 days
×
Clear all
No trials found.